DataMEDS Si Licenses U.S. Rights To Reboot Health AI's Direct-To-Consumer GLP-1 Weight Management Platform
DataMeds AI announced an exclusive U.S. direct-to-consumer license, revenue-sharing and marketing agreement with REBOOT Health AI for its GLP-1 care management platform. The companies plan to tailor it for integration into the Health Lives Here app as a subscription offering.
Why it matters — The announcement concerns DataMeds AI and its planned app integration, with no stated connection to Datavault AI (DVLT).